Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce ...
SurvivorNet on MSN
Could timing give your cancer treatment a boost? New study on the best time to receive immunotherapy & chemo for non-small cell lung cancer
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...
SurvivorNet on MSN
More control, better quality of life: What to know about tarlatamab, the new immunotherapy drug approved for small-cell lung cancer
Tarlatamab (Imdelltra) is a new type of immunotherapy approved for people with small-cell lung cancer whose disease has progressed after chemotherapy and immunotherapy.
MedPage Today on MSN
Time of Day Matters for Immunochemotherapy in Lung Cancer
This is a "landmark study" for cancer immunotherapy and circadian medicine, researcher say ...
University of Queensland researchers who mapped cancer cell "neighborhoods" in the most common type of lung cancer have found ...
This is the first trial combining Allarity’s stenoparib with another anti-cancer agentStenoparib’s favorable safety profile supports ...
Dr. Charles M. Rudin discussed recent treatment advancements for patients with small cell lung cancer. During the CURE Educated Patient® Lung Cancer Summit, held in tandem with the 2025 PER® New York ...
Scientists in Australia have mapped the "neighbourhoods" of lung cancer cells and found that cell metabolism plays a key role ...
Research reveals the efficacy of cancer therapies and organ transplant treatments may improve by synchronizing with the ...
Key opportunities in the Global Small Cell Lung Cancer Therapeutics Market include the growing demand for advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results